Abstract
It is well known that brain natriuretic peptide (BNP) is elevated in the acute phase of Kawasaki disease (KD). We hypothesized that mitral annular plane systolic excursion (MAPSE) could identify LV dysfunction in the acute phase of KD. Fifty patients with KD were enrolled in this study. BNP sampling and an echocardiographic study were performed just before and after intravenous immunoglobulin administration. MAPSE was measured in M-mode in the apical four-chamber view. The %MAPSE was calculated as the MAPSE measured in the acute phase divided by that measured in the convalescent phase. We compared the acute and the convalescent phases of KD. The values of the MAPSE were significantly reduced (45 out of 50 patients) during the acute phase and immediately recovered in the convalescent phase (10.0 ± 1.9 vs. 12.7 ± 1.9 mm, P < 0.0001). Of the parameters tested, %MAPSE was the only echocardiographic parameter that was associated with Log-BNP. Additionally, %MAPSE had a significant negative correlation with Log-BNP (r = −0.45, P < 0.0039). Longitudinal LV contraction is impaired in the acute phase of KD, but it immediately recovers in the convalescent phase. Measuring the longitudinal LV contractility should be essential for evaluating LV function in the acute phase of KD, and MAPSE is useful for this evaluation.
Similar content being viewed by others
References
Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K, Kawasaki Disease Research C (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232–234
Bang S, Yu JJ, Han MK, Ko HK, Chun S, Choi HS, Kim YH, Ko JK, Park IS (2011) Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction. Korean J Pediatr 54:340–344
Bergenzaun L, Ohlin H, Gudmundsson P, Willenheimer R, Chew MS (2013) Mitral annular plane systolic excursion (MAPSE) in shock: a valuable echocardiographic parameter in intensive care patients. Cardiovasc Ultrasound 11:16
Burns JC, Glodé MP (2004) Kawasaki syndrome. Lancet 364:533–544
Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ (2011) Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP? Ann Clin Lab Sci 41:360–363
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817
Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805–810
Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, Akimoto K, Takahashi K, Kishiro M, Shimizu T (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61:1156–1167
Hashimoto I, Watanabe K (2014) Alternation of right ventricular contraction pattern in healthy children. Circ J 78:1967–1973
Hu K, Liu D, Herrmann S, Niemann M, Gaudron PD, Voelker W, Ertl G, Bijnens B, Weidemann F (2013) Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. Eur Heart J Cardiovasc Imaging 14:205–212
Iwashima S, Ishikawa T (2013) B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease. World J Pediatr 9:239–244
Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S (2011) Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr Cardiol 32:1106–1109
Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248
Kishimoto S, Suda K, Teramachi Y, Nishino H, Kudo Y, Ishii H, Iemura M, Takahashi T, Okamura H, Matsuishi T (2011) Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease. Pediatr Int 53:736–741
Kitabatake A, Inoue M, Asao M, Ito H, Masuyama T, Tanouchi J, Morita T, Hori M, Yoshima H, Ohnishi K, Abe H (1984) Noninvasive evaluation of the ratio of pulmonary to systemic flow in atrial septal defect by duplex Doppler echocardiography. Circulation 69:73–79
Koestenberger M, Nagel B, Ravekes W, Avian A, Heinzl B, Fritsch P, Fandl A, Rehak T, Gamillscheg A (2012) Left ventricular long-axis function: reference values of the mitral annular plane systolic excursion in 558 healthy children and calculation of z-score values. Am Heart J 164:125–131
Koteda Y, Suda K, Kishimoto S, Ito S, Kudo Y, Nishino H, Ishii H, Iemura M, Matuishi T (2009) Impact of intravenous immunoglobulin infusion on longitudinal left ventricular performance in patients with acute Kawasaki disease of usual course. J Cardiol 54:45–51
Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, Kogaki S, Ozono K (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26:425–430
Lisi M, Ballo P, Cameli M, Gandolfo F, Galderisi M, Chiavarelli M, Henein MY, Mondillo S (2012) Mitral annular longitudinal function preservation after mitral valve repair: the MARTE study. Int J Cardiol 157:212–215
Matos J, Kronzon I, Panagopoulos G, Perk G (2012) Mitral annular plane systolic excursion as a surrogate for left ventricular ejection fraction. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr 25:969–974
Matsubara T (1991) Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease. Arerugi (Allergy) 40:147–154
McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon SC (2013) Myocardial strain and strain rate in Kawasaki disease. Eur Heart J Cardiovasc Imaging 14:1061–1068
McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW, Pediatric Heart Network I (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179
Ogawa T, de Bold AJ (2012) Uncoordinated regulation of atrial natriuretic factor and brain natriuretic peptide in lipopolysaccharide-treated rats. Biomarkers : Biochem Indic Expo Response Susceptibility Chem 17:140–149
Pombo JF, Troy BL, Russell RO Jr (1971) Left ventricular volumes and ejection fraction by echocardiography. Circulation 43:480–490
Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW (2012) Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 25:733–740
Sato N, Sagawa K, Sasaguri Y, Inoue O, Kato H (1993) Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J Pediatr 122:198–203
Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K, Maeda J (1996) Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 155:291–296
Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362
Tanaka T, Kanda T, Takahashi T, Saegusa S, Moriya J, Kurabayashi M (2004) Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 32:57–61
Teichholz LE, Cohen MV, Sonnenblick EH, Gorlin R (1974) Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med 291:1220–1226
Torrent-Guasp F, Buckberg GD, Clemente C, Cox JL, Coghlan HC, Gharib M (2001) The structure and function of the helical heart and its buttress wrapping. I. The normal macroscopic structure of the heart. Semin Thorac Cardiovasc Surg 13:301–319
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K (2013) N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. J Pediatr 162:1205–1209
Yu JJ, Choi HS, Kim YB, Son JS, Kim YH, Ko JK, Park IS (2010) Analyses of left ventricular myocardial deformation by speckle-tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol 31:807–812
Acknowledgments
The authors have no grant or other financial support.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hashimoto, I., Watanabe, K., Okabe, M. et al. Impairment of Left Ventricular Longitudinal Contraction is Associated with Serum Brain Natriuretic Peptide Concentration in Patients with Acute-Phase Kawasaki Disease. Pediatr Cardiol 36, 979–986 (2015). https://doi.org/10.1007/s00246-015-1108-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-015-1108-6